NCT00462423 Abraxane and Avastin as Therapy for Patients With Malignant Melanoma, a Phase II Study Status COMPLETED Phase PHASE2
NCT00454324 Study of Abraxane and Carboplatin to Treat Small Cell Lung Cancer Status TERMINATED Phase PHASE2
NCT00442260 Doxorubicin HCL Liposome Injection (DOXIL) in Combination With Abraxane in Patients With Metastatic Breast Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00407563 Bevacizumab With Abraxane in Patients With Recurrent Ovarian/ Peritoneal Cancer Status COMPLETED Phase PHASE2
NCT00337376 A Study of the mTOR Inhibitor Rapamycin (Rapamune, Sirolimus) in Combination With Abraxane in Advanced Solid Cancers Status TERMINATED Phase PHASE1
NCT00319839 Study of Albumin Bound-Paclitaxel for Treatment of Recurrent or Metastatic Head and Neck Cancer With Cetuximab Status TERMINATED Phase PHASE2
NCT00284752 Phase II Trial of Abraxane in Front Line Therapy of Hormone Refractory Metastatic Prostate Cancer Status COMPLETED Phase PHASE2
NCT00107094 Study of Adriamycin Plus Cyclophosphamide Followed by Abraxane as Adjuvant Therapy for Patients With Breast Cancer Status COMPLETED Phase PHASE1